EPL Blog Pathology Peer Review

Experimental Pathology Laboratories, Inc. (EPL) meets or exceeds current FDA guidelines following the release of "Pathology Peer Review in Nonclinical Studies: Questions and Answers, Guidance for Industry" document in December 2021 (https://www.fda.gov/media/129533/download) At EPL we pride ourselves on providing our clients with not only the best services possible, but also with the up to the [...]The post Pathology Peer Review appeared first on EPL, Inc - GLP Histology, Toxicologic Pathology for Pharmaceutical Research and Development.